Stock Price

Discussion in 'Insys Therapeutics' started by anonymous, Aug 12, 2017 at 1:12 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Let's bring in all of opioid kingpin Purdue's rejects who haven't a clue how to sell niche products, bring that big pharma mentality to a tiny biotech company, demotivate the entire sales force with a new micro management culture and watch the stock go to zero because everyone is MISERABLE, DISENGAGED, and investors can't fathom why Insys would hire from Purdue. Bonuses are capped, salary is still way too low for industry standards and all the key players that were detrimental in keeping us alive are jumping off the new "PurdInsys" train wreck. We are way top heavy now on unnecessary exec salaries... hey new guys - why don't you lead by example and show us how you can get it done!!!
     

  2. anonymous

    anonymous Guest

    I think your use of the word detrimental instead of instrumental was a Freudian slip regarding the bogus speaker programs and off label promoting that the key players were involved in.